Cellectar Biosciences Stock Price on December 16, 2024

CLRB Stock  USD 0.28  0.02  7.69%   
If you're considering investing in Cellectar Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cellectar Biosciences stands at 0.28, as last reported on the 7th of February, with the highest price reaching 0.29 and the lowest price hitting 0.26 during the day. Cellectar Biosciences secures Sharpe Ratio (or Efficiency) of -0.18, which signifies that the company had a -0.18 % return per unit of risk over the last 3 months. Cellectar Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cellectar Biosciences' Mean Deviation of 5.62, standard deviation of 11.52, and Risk Adjusted Performance of (0.14) to double-check the risk estimate we provide.
  
Cellectar Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1821

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCLRB

Estimated Market Risk

 11.62
  actual daily
96
96% of assets are less volatile

Expected Return

 -2.12
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.18
  actual daily
0
Most of other assets perform better
Based on monthly moving average Cellectar Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cellectar Biosciences by adding Cellectar Biosciences to a well-diversified portfolio.

Related Headline

Monopar Therapeutics Headline on 16th of December 2024

Filed transaction by Monopar Therapeutics Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Cellectar Biosciences Valuation on December 16, 2024

It is possible to determine the worth of Cellectar Biosciences on a given historical date. On December 16, 2024 Cellectar was worth 0.27 at the beginning of the trading date compared to the closed value of 0.26. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cellectar Biosciences stock. Still, in general, we apply an absolute valuation method to find Cellectar Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cellectar Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cellectar Biosciences' related companies.
 Open High Low Close Volume
  0.26    0.27    0.23    0.26    7,347,101  
12/16/2024
  0.27    0.27    0.24    0.26    5,723,053  
  0.25    0.28    0.24    0.26    3,496,070  
Backtest Cellectar Biosciences  |  Cellectar Biosciences History  |  Cellectar Biosciences Valuation   PreviousNext  
Open Value
0.27
0.26
Closing Value
35.13
Upside

Cellectar Biosciences Trading Date Momentum on December 16, 2024

On December 17 2024 Cellectar Biosciences was traded for  0.26  at the closing time. The top price for the day was 0.28  and the lowest listed price was  0.24 . The trading volume for the day was 3.5 M. The trading history from December 17, 2024 did not affect price variability. The overall trading delta against the current closing price is 3.85% .

Cellectar Biosciences Fundamentals Correlations and Trends

By evaluating Cellectar Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cellectar Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cellectar financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Cellectar Biosciences Stock history

Cellectar Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cellectar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cellectar Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cellectar Biosciences stock prices may prove useful in developing a viable investing in Cellectar Biosciences
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. The company was founded in 2002 and is headquartered in Florham Park, New Jersey. Cellectar Biosc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.

Cellectar Biosciences Stock Technical Analysis

Cellectar Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cellectar Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cellectar Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Cellectar Biosciences Period Price Range

Low
February 7, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Cellectar Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Cellectar Biosciences February 7, 2025 Market Strength

Market strength indicators help investors to evaluate how Cellectar Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cellectar Biosciences shares will generate the highest return on investment. By undertsting and applying Cellectar Biosciences stock market strength indicators, traders can identify Cellectar Biosciences entry and exit signals to maximize returns

Cellectar Biosciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cellectar Biosciences' price direction in advance. Along with the technical and fundamental analysis of Cellectar Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cellectar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Cellectar Stock analysis

When running Cellectar Biosciences' price analysis, check to measure Cellectar Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectar Biosciences is operating at the current time. Most of Cellectar Biosciences' value examination focuses on studying past and present price action to predict the probability of Cellectar Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectar Biosciences' price. Additionally, you may evaluate how the addition of Cellectar Biosciences to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Correlations
Find global opportunities by holding instruments from different markets